ProductDescription
PTC-124(Ataluren)isanoxADIazole-based,orallyavailableagentdeisgnedtoselectivelypromoteribosomalreadhtroughofprematurestopcodons,butnotnormalterminationcodons.[1]TheminimalconcentrationofPTC124showingobservablereadthroughwas0.01-0.1uM(2.8-28ng/ml),whilemaximalactivitywasobservedat3uM(852ng/ml).[2]
PTC-124hasbeenstudiedextensivelyinthetreatmentofcysticfibrosisandhasshowngoodtolerABIlityandefficacyinpreclinicalandclinicalsettings.[3,4]
Technicalinformation:
ChemicalFormula: | C15H9FN2O3 | |
CAS#: | 775304-57-9 | |
MolecularWeight: | 284.24 | |
Purity: | >98% | |
Appearance: | White | |
ChemicalName: | 3-(5-(2-fluorophenyl)-1,2,4-oxadiazol-3-yl)benzoicacid | |
Solubility: | Upto100mMinDMSO | |
Synonyms: | PTC-124,PTC124,PTC124 |
ShippingCondition:Theproductisshippedinaglassvialatambienttemperature.
Storagecondition:Forlongershelflife,storesolidpowderat4oCdesiccated,orstoreDMSOsolutionat-20oC.
Reference:
1. | Sermet-Gaudelusetal.,Ataluren(PTC124)inducescysticfibrosistransmembraneconductanceregulatorproteinexpressionandactivityinchildrenwithnonsensemutationcysticfibrosis.Am.J.Respir.Crit.CareMed.2010,182,1262-1272.PubmedID:20622033 |
2. | Welchetal.,PTC124targetsgeneticdisorderscausedbynonsensemutations.Nature,2007,447,87-91.PubmedID:17450125 |
3. | Duetal.,PTC124isanorallybioavailablecompoundthatpromotessuppressionofthehumanCFTR-G542XnonsensealleleinaCFmousemodel.Proc.Natl.Acad.Sci.2008,105(6),2064-2069PubmedID:18272502 |
4. | Wilschanskietal.,Chronicataluren(PTC124)treatmentofnonsensemutationcysticfibrosis.Eur.Respir.J.2011,38,59-69.PubmedID:17450125 |
Cellagen的ChamQ SYBR qPCR预混液(无ROX)| Q321产品描述ChamQSYBR®qPCR预混液(Vazyme,#Q321)由香槟Taq DNA聚合酶(Vazyme,#P122)通过抗体修饰的热启动激活技术保护,是专为基于SYBR Green I的定量PCR(qPCR)设计的。ChamQSYBR®qPCR Master Mix的优化缓冲液系统中的独特因素(即促进特异性的Exactor)大大提高了其灵敏度和特异性。该混合物以2倍反应浓度制备,可直接用于鲁棒性低模板qPCR,具有高灵敏度,特异性和可靠性。优点特异性+敏感性的最佳组合。独特的抗体修饰的热启动taq,具有独特的特异性促进因子。Mg2 +和染料的最佳浓度。